Southeast Asian pharmaceuticals platform SwipeRx has secured $10 million in fresh funding as part of a new Series B2 round led by global pharma giant Sanofi’s global health unit and Cercano Management (formerly Vulcan Capital), the company announced on Thursday.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
